Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug shows promise in early trial for advanced cancers

NCT ID NCT05378737

Completed Disease control Sponsor: Bio-Thera Solutions Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase study tested a new drug called BAT8006 in 216 adults with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the best dose for future studies. This is not a cure, but a step toward better control of the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer endometrial cancer fallopian tube cancer neoplasm non-small cell lung carcinoma ovarian carcinoma primary peritoneal carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMORS

Contacts and locations

Locations

  • Anhui Cancer Hospital

    Hefei, Anhui, China

  • Beijing Obstetrics and Gynecology Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

  • Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center

    Shenzhen, Guangdong, China

  • Fujian Cancer Hospital

    Fuzhou, Fujian, China

  • Guangxi Medical University Cancer Hospital & Guangxi Cancer Institute

    Nanning, Guangxi, China

  • Hubei Cancer Hospital

    Wuhan, Hubei, China

  • Hunan Cancer Hospital

    Changsha, Hunan, China

  • Liaoning Cancer Hospital&Institute

    Shenyang, Liaoning, China

  • Shandong Cancer Hospital

    Jinan, Shandong, China

  • Shanxi Provincial Cancer Hospital

    Taiyuan, Shanxi, China

  • Sun Yat-Sen Memorlal Hospital, Sun Yat-Sen University

    Guangzhou, Guangdong, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, China

  • The First Hospital of Jilin University

    Changchun, Jilin, China

  • Tianjin Medical University Cancer Institute & Hospital

    Tianjin, Tianjin Municipality, China

  • Tongji Hospital, Tongji Medical College of Hust

    Wuhan, Hubei, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, China

  • Zhongnan Hospital of Wuhan University

    Wuhan, Hubei, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.